Zong M, Bruton JD, Grundtman C, Yang H, Li JH, Alexanderson H, Palmblad K, Andersson U, Harris HE, Lundberg IE, Westerblad H: TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann Rheum Dis. 2012, Epub ahead of print
Google Scholar
Coley W, Rayavarapu S, Pandey GS, Sabina RL, Van der Meulen JH, Ampong B, Wortmann RL, Rawat R, Nagaraju K: The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy. Arthritis Rheum. 2012, 64: 3750-3759. 10.1002/art.34625.
PubMed Central
CAS
PubMed
Google Scholar
Alger HM, Raben N, Pistilli E, Francia DL, Rawat R, Getnet D, Ghimbovschi S, Chen YW, Lundberg IE, Nagaraju K: The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage. Arthritis Rheum. 2011, 63: 3448-3457. 10.1002/art.30530.
PubMed Central
CAS
PubMed
Google Scholar
Lu YC, Yeh WC, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine. 2008, 42: 145-151. 10.1016/j.cyto.2008.01.006.
CAS
PubMed
Google Scholar
Grundtman C, Bruton J, Yamada T, Ostberg T, Pisetsky DS, Harris HE, Andersson U, Lundberg IE, Westerblad H: Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 2010, 24: 570-578. 10.1096/fj.09-144782.
CAS
PubMed
Google Scholar
Ulfgren AK, Grundtman C, Borg K, Alexanderson H, Andersson U, Harris HE, Lundberg IE: Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum. 2004, 50: 1586-1594. 10.1002/art.20220.
CAS
PubMed
Google Scholar
Schreiner B, Voss J, Wischhusen J, Dombrowski Y, Steinle A, Lochmüller H, Dalakas M, Melms A, Wiendl H: Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J. 2006, 20: 118-120.
CAS
PubMed
Google Scholar
Kim GT, Cho ML, Park YE, Yoo WH, Kim JH, Oh HJ, Kim DS, Baek SH, Lee SH, Lee JH, Kim HY, Kim SI: Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol. 2010, 29: 273-279. 10.1007/s10067-009-1316-7.
PubMed Central
PubMed
Google Scholar
Tournadre A, Lenief V, Miossec P: Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum. 2010, 62: 2144-2151.
CAS
PubMed
Google Scholar
Brunn A, Zornbach K, Hans VH, Haupt WF, Deckert M: Toll-like receptors promote inflammation in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol. 2012, 71: 855-867. 10.1097/NEN.0b013e31826bf7f3.
CAS
PubMed
Google Scholar
Wang H, Hertlein E, Bakkar N, Sun H, Acharyya S, Wang J, Carathers M, Davuluri R, Guttridge DC: NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol Cell Biol. 2007, 27: 4374-4387. 10.1128/MCB.02020-06.
PubMed Central
CAS
PubMed
Google Scholar
Bakkar N, Wang J, Ladner KJ, Wang H, Dahlman JM, Carathers M, Acharyya S, Rudnicki MA, Hollenbach AD, Guttridge DC: IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol. 2008, 180: 787-802. 10.1083/jcb.200707179.
PubMed Central
CAS
PubMed
Google Scholar
Creus KK, De Paepe B, Werbrouck BF, Vervaet V, Weis J, De Bleecker JL: Distribution of the NF-kappaB complex in the inflammatory exudates characterizing the idiopathic inflammatory myopathies. Ann N Y Acad Sci. 2009, 1173: 370-377. 10.1111/j.1749-6632.2009.04874.x.
CAS
PubMed
Google Scholar
Lu YC, Kim I, Lye E, Shen F, Suzuki N, Gerondakis S, Akira S, Gaffen SL, Yeh WC, Ohashi PS: Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol. 2009, 182: 7212-7221. 10.4049/jimmunol.0802971.
PubMed Central
CAS
PubMed
Google Scholar
Medzhitov R, Preston-Hurlburt P, Janeway CA: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997, 388: 394-397. 10.1038/41131.
CAS
PubMed
Google Scholar
Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA. 1998, 95: 588-593. 10.1073/pnas.95.2.588.
PubMed Central
CAS
PubMed
Google Scholar
Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E: High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006, 290: C917-C924.
CAS
PubMed
Google Scholar
Zhang P, Cox CJ, Alvarez KM, Cunningham MW: Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol. 2009, 183: 27-31. 10.4049/jimmunol.0800861.
PubMed Central
CAS
PubMed
Google Scholar
Foell D, Wittkowski H, Roth J: Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol. 2007, 3: 382-390.
CAS
PubMed
Google Scholar
Foell D, Wittkowski H, Vogl T, Roth J: S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007, 81: 28-37.
CAS
PubMed
Google Scholar
Ionita MG, Arslan F, de Kleijn DP, Pasterkamp G: Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease. J Innate Immun. 2010, 2: 307-315. 10.1159/000314270.
CAS
PubMed
Google Scholar
Tournadre A, Lenief V, Eljaafari A, Miossec P: Immature muscle precursors are a source of interferon-beta in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 2012, 64: 533-541.
CAS
PubMed
Google Scholar
Zhang HY, Kang J, Han WJ, Hu MM, Jia HG: The expression and significance of TLR4, MyD88 and NF-kappaB mRNA in mouse lymph node of experimental autoimmune myositis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012, 28: 272-275.
CAS
PubMed
Google Scholar
Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, Casciola-Rosen L, Härtlein M, Kron M, Yang D, Yiadom K, Dwivedi S, Plotz PH, Oppenheim JJ: Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med. 2002, 196: 781-791. 10.1084/jem.20020186.
PubMed Central
CAS
PubMed
Google Scholar
Harlow L, Fernandez I, Soejima M, Ridgway WM, Ascherman DP: Characterization of TLR4-mediated auto-antibody production in a mouse model of histidyl-tRNA synthetase-induced myositis. Innate Immun. 2012, 18: 876-885. 10.1177/1753425912446714.
PubMed
Google Scholar
Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, Corse A, Rosen A: Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med. 2005, 201: 591-601. 10.1084/jem.20041367.
PubMed Central
CAS
PubMed
Google Scholar
Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, Chang J, Dwivedi S, Mitsak M, Chen YW, Plotz P, Rosen A, Hoffman E, Raben N: Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 2005, 52: 1824-1835. 10.1002/art.21103.
CAS
PubMed
Google Scholar
Monici MC, Aguennouz M, Mazzeo A, Messina C, Vita G: Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology. 2003, 60: 993-997. 10.1212/01.WNL.0000049913.27181.51.
CAS
PubMed
Google Scholar
Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006, 440: 228-232. 10.1038/nature04515.
CAS
PubMed
Google Scholar
Yamasaki K, Muto J, Taylor KR, Cogen AL, Audish D, Bertin J, Grant EP, Coyle AJ, Misaghi A, Hoffman HM, Gallo RL: NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem. 2009, 284: 12762-12771. 10.1074/jbc.M806084200.
PubMed Central
CAS
PubMed
Google Scholar
Bryant C, Fitzgerald KA: Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 2009, 19: 455-464. 10.1016/j.tcb.2009.06.002.
CAS
PubMed
Google Scholar
Rawat R, Cohen TV, Ampong B, Francia D, Henriques-Pons A, Hoffman EP, Nagaraju K: Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am J Pathol. 2010, 176: 2891-2900. 10.2353/ajpath.2010.090058.
PubMed Central
CAS
PubMed
Google Scholar
Segovia J, Sabbah A, Mgbemena V, Tsai SY, Chang TH, Berton MT, Morris IR, Allen IC, Ting JPY, Bose S: TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One. 2012, 7: e29695-10.1371/journal.pone.0029695.
PubMed Central
CAS
PubMed
Google Scholar
Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L: Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997, 40: 865-874. 10.1002/art.1780400514.
CAS
PubMed
Google Scholar
Lundberg I, Brengman JM, Engel AG: Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol. 1995, 63: 9-16. 10.1016/0165-5728(95)00122-0.
CAS
PubMed
Google Scholar
Authier FJ, Mhiri C, Chazaud B, Christov C, Cherin P, Barlovatz-Meimon G, Gherardi RK: Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes. Neuropathol Appl Neurobiol. 1997, 23: 132-140. 10.1111/j.1365-2990.1997.tb01195.x.
CAS
PubMed
Google Scholar
De Bleecker JL, Meire VI, Declercq W, Van Aken EH: Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul Disord. 1999, 9: 239-246. 10.1016/S0960-8966(98)00126-6.
CAS
PubMed
Google Scholar
Tateyama M, Nagano I, Yoshioka M, Chida K, Nakamura S, Itoyama Y: Expression of tumor necrosis factor-alpha in muscles of polymyositis. J Neurol Sci. 1997, 146: 45-51. 10.1016/S0022-510X(96)00280-8.
CAS
PubMed
Google Scholar
Confalonieri P, Bernasconi P, Cornelio F, Mantegazza R: Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J Neuropathol Exp Neurol. 1997, 56: 479-484. 10.1097/00005072-199705000-00003.
CAS
PubMed
Google Scholar
Chevrel G, Granet C, Miossec P: Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis. 2005, 64: 1257-1262. 10.1136/ard.2004.032359.
PubMed Central
CAS
PubMed
Google Scholar
Tournadre A, Porcherot M, Cherin P, Marie I, Hachulla E, Miossec P: Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins. Cytokine. 2009, 46: 297-301. 10.1016/j.cyto.2009.02.013.
CAS
PubMed
Google Scholar
Cappelletti C, Baggi F, Zolezzi F, Biancolini D, Beretta O, Severa M, Coccia EM, Confalonieri P, Morandi L, Mora M, Mantegazza R, Bernasconi P: Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies. Neurology. 2011, 76: 2079-2088. 10.1212/WNL.0b013e31821f440a.
CAS
PubMed
Google Scholar
Eloranta ML, Barbasso Helmers S, Ulfgren AK, Ronnblom L, Alm GV, Lundberg IE: A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum. 2007, 56: 3112-3124. 10.1002/art.22860.
CAS
PubMed
Google Scholar
Greenberg SA, Higgs BW, Morehouse C, Walsh RJ, Kong SW, Brohawn P, Zhu W, Amato A, Salajegheh M, White B, Kiener PA, Jallal B, Yao Y: Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Genes Immun. 2012, 13: 207-213. 10.1038/gene.2011.61.
CAS
PubMed
Google Scholar
Loell I, Alemo Munters L, Pandya J, Zong M, Alexanderson H, Fasth AE, Hallengren CS, Rådmark O, Lundberg IE, Jakobsson PJ, Korotkova M: Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis. Ann Rheum Dis. 2012, 72: 293-299.
PubMed
Google Scholar
Adams EM, Kirkley J, Eidelman G, Dohlman J, Plotz PH: The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases. Proc Assoc Am Physicians. 1997, 109: 275-285.
CAS
PubMed
Google Scholar
Filkova M, Hulejova H, Kuncova K, Plestilova L, Cerezo LA, Mann H, Klein M, Zámečník J, Gay S, Vencovský J, Senolt L: Resistin in idiopathic inflammatory myopathies. Arthritis Res Ther. 2012, 14: R111-10.1186/ar3836.
PubMed Central
CAS
PubMed
Google Scholar
Filkova M, Haluzik M, Gay S, Senolt L: The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009, 133: 157-170. 10.1016/j.clim.2009.07.013.
CAS
PubMed
Google Scholar
Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.
CAS
PubMed
Google Scholar
Morosetti R, Gliubizzi C, Sancricca C, Broccolini A, Gidaro T, Lucchini M, Mirabella M: TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis. Am J Pathol. 2012, 180: 1603-1613. 10.1016/j.ajpath.2011.12.027.
CAS
PubMed
Google Scholar
Zong M, Loell I, Lindroos E, Nader GA, Alexanderson H, Hallengren CS, Borg K, Arnardottir S, McInnes IB, Lundberg IE: Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor alpha expression in muscle tissue of patients with polymyositis or dermatomyositis. Ann Rheum Dis. 2012, 71: 1055-1063. 10.1136/annrheumdis-2011-200495.
CAS
PubMed
Google Scholar
Colombo E, Romaggi S, Blasevich F, Mora M, Falcone C, Lochmüller H, Morandi L, Farina C: The neurotrophin receptor p75NTR is induced on mature myofibres in inflammatory myopathies and promotes myotube survival to inflammatory stress. Neuropathol Appl Neurobiol. 2012, 38: 367-378. 10.1111/j.1365-2990.2011.01212.x.
CAS
PubMed
Google Scholar
Bettelli E, Oukka M, Kuchroo VK: T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007, 8: 345-350.
CAS
PubMed
Google Scholar
Rostasy KM, Piepkorn M, Goebel HH, Menck S, Hanefeld F, Schulz-Schaeffer WJ: Monocyte/macrophage differentiation in dermatomyositis and polymyositis. Muscle Nerve. 2004, 30: 225-230. 10.1002/mus.20088.
PubMed
Google Scholar
Rostasy KM, Schmidt J, Bahn E, Pfander T, Piepkorn M, Wilichowski E, Schulz-Schaeffer J: Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies. Acta Myol. 2008, 27: 49-53.
PubMed Central
CAS
PubMed
Google Scholar
Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, Nennesmo I, Malmberg KJ, Söderberg-Nauclér C, Trollmo C, Lundberg IE, Malmström V: T-cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T-cells. J Immunol. 2009, 183: 4792-4799. 10.4049/jimmunol.0803688.
CAS
PubMed
Google Scholar
Waschbisch A, Schwab N, Ruck T, Stenner MP, Wiendl H: FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J Neuroimmunol. 2010, 225: 137-142. 10.1016/j.jneuroim.2010.03.013.
CAS
PubMed
Google Scholar
Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, Johnson MA, Wekerle H, Tschopp J, Jenne D, Hohlfeld R: Differential expression of perforin in muscle-infiltrating T-cells in polymyositis and dermatomyositis. J Clin Invest. 1996, 97: 2905-2910. 10.1172/JCI118749.
PubMed Central
CAS
PubMed
Google Scholar
Arahata K, Engel AG: Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T-cells. Ann Neurol. 1984, 16: 193-208. 10.1002/ana.410160206.
CAS
PubMed
Google Scholar
Arahata K, Engel AG: Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol. 1986, 19: 112-125. 10.1002/ana.410190203.
CAS
PubMed
Google Scholar
Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, Due B, Bregoli L, O'Connor KC, Amato AA: Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology. 2005, 65: 1782-1787. 10.1212/01.wnl.0000187124.92826.20.
CAS
PubMed
Google Scholar
Salajegheh M, Pinkus JL, Amato AA, Morehouse C, Jallal B, Yao Y, Greenberg SA: Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles. Muscle Nerve. 2010, 42: 576-583. 10.1002/mus.21739.
PubMed
Google Scholar
Nishikai M, Reichlin M: Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980, 23: 881-888. 10.1002/art.1780230802.
CAS
PubMed
Google Scholar
Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M: The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 1983, 26: 604-611. 10.1002/art.1780260505.
CAS
PubMed
Google Scholar
Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP: Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 2007, 56: 3125-3131. 10.1002/art.22865.
CAS
PubMed
Google Scholar
Reichlin M, Mattioli M: Description of a serological reaction characteristic of polymyositis. Clin Immunol Immunopathol. 1976, 5: 12-20. 10.1016/0090-1229(76)90145-8.
CAS
PubMed
Google Scholar
Targoff IN, Reichlin M: The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985, 28: 796-803. 10.1002/art.1780280711.
CAS
PubMed
Google Scholar
Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, Nishikawa T, Oddis CV, Ikeda Y: Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005, 52: 1571-1576. 10.1002/art.21023.
CAS
PubMed
Google Scholar
Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, Kawabata D, Ohmura K, Usui T, Fujii T, Okawa K, Mimori T: The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford). 2010, 49: 433-440. 10.1093/rheumatology/kep375.
CAS
Google Scholar
Chaisson NF, Paik J, Orbai AM, Casciola-Rosen L, Fiorentino D, Danoff S, Rosen A: A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature. Medicine (Baltimore). 2012, 91: 220-228. 10.1097/MD.0b013e3182606f0b.
Google Scholar
Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, Miller FW, Rider LG, Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group: A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006, 54: 3682-3689. 10.1002/art.22164.
CAS
PubMed
Google Scholar
Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, Matsushita T, Orito H, Hamaguchi Y, Yanaba K, Itoh M, Asano Y, Seishima M, Ogawa F, Sato S, Takehara K: Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007, 46: 25-28. 10.1093/rheumatology/kel161.
CAS
Google Scholar
Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, Ishiguro N, Ueda-Hayakawa I, Asano Y, Ogawa F, Fujikawa K, Miyagi T, Mabuchi E, Hirose K, Akimoto N, Hatta N, Tsutsui K, Higashi A, Igarashi A, Seishima M, Hasegawa M, Takehara K: Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 2012, 64: 513-522. 10.1002/art.33403.
CAS
PubMed
Google Scholar
Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ, Juvenile Dermatomyositis Research Group, UK and Ireland: Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 2009, 60: 1807-1814. 10.1002/art.24547.
PubMed Central
CAS
PubMed
Google Scholar
Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A: Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods. 2012, 384: 128-134. 10.1016/j.jim.2012.07.019.
CAS
PubMed
Google Scholar
Reeves WH, Nigam SK, Blobel G: Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci USA. 1986, 83: 9507-9511. 10.1073/pnas.83.24.9507.
PubMed Central
CAS
PubMed
Google Scholar
Targoff IN, Johnson AE, Miller FW: Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990, 33: 1361-1370. 10.1002/art.1780330908.
CAS
PubMed
Google Scholar
Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG: Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis. 2006, 65: 1635-1638. 10.1136/ard.2006.052191.
PubMed Central
CAS
PubMed
Google Scholar
Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O: Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011, 63: 1961-1971. 10.1002/art.30344.
CAS
PubMed
Google Scholar
Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL: A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010, 62: 2757-2766. 10.1002/art.27572.
PubMed Central
CAS
PubMed
Google Scholar
Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA: Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011, 63: 713-721. 10.1002/art.30156.
PubMed Central
CAS
PubMed
Google Scholar
Casciola-Rosen L, Mammen AL: Myositis autoantibodies. Curr Opin Rheumatol. 2012, 24: 602-608. 10.1097/BOR.0b013e328358bd85.
CAS
PubMed
Google Scholar
Mammen AL: Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci. 2010, 1184: 134-153. 10.1111/j.1749-6632.2009.05119.x.
CAS
PubMed
Google Scholar
Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K: IL-12 up-regulates IL-18 receptor expression on T-cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol. 1998, 161: 3400-3407.
CAS
PubMed
Google Scholar
Smeltz RB, Chen J, Ehrhardt R, Shevach EM: Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression. J Immunol. 2002, 168: 6165-6172.
CAS
PubMed
Google Scholar
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005, 23: 479-490. 10.1016/j.immuni.2005.09.015.
CAS
PubMed
Google Scholar
Nagaraju K, Rider LG, Fan C, Chen YW, Mitsak M, Rawat R, Patterson K, Grundtman C, Miller FW, Plotz PH, Hoffman E, Lundberg IE: Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis. 2006, 3: 2-10.1186/1740-2557-3-2.
PubMed Central
PubMed
Google Scholar
Page G, Chevrel G, Miossec P: Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 2004, 50: 199-208. 10.1002/art.11428.
CAS
PubMed
Google Scholar
Gendek-Kubiak H, Gendek EG: Fascin-expressing Dendritic Cells Dominate in Polymyositis and Dermatomyositis. J Rheumatol. 2012, 40: 186-191.
PubMed
Google Scholar
Maddur MS, Vani J, Lacroix-Desmazes S, Kaveri SV, Bayry J: Contribution of myeloid dendritic cells to type I interferon-induced cytokines and chemokines: comment on the article by Bilgic et al. Arthritis Rheum. 2010, 62: 2181-2182. Author reply 2182
PubMed
Google Scholar
Facchetti F, Vergoni F: The plasmacytoid monocyte: from morphology to function. Adv Clin Path. 2000, 4: 187-190.
CAS
PubMed
Google Scholar
Kadowaki N, Antonenko S, Liu YJ: Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c + dendritic cells to produce type I IFN. J Immunol. 2001, 166: 2291-2295.
CAS
PubMed
Google Scholar
Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S, Reith W, Ludewig B, Reizis B: Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci USA. 2012, 109: 3012-3017. 10.1073/pnas.1117359109.
PubMed Central
CAS
PubMed
Google Scholar
Nogalska A, Engel WK, McFerrin J, Kokame K, Komano H, Askanas V: Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers. J Neurochem. 2006, 96: 1491-1499. 10.1111/j.1471-4159.2006.03668.x.
CAS
PubMed
Google Scholar
Nogalska A, Wojcik S, Engel WK, McFerrin J, Askanas V: Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis. Exp Neurol. 2007, 204: 610-618. 10.1016/j.expneurol.2006.12.014.
PubMed Central
CAS
PubMed
Google Scholar
Li CK, Knopp P, Moncrieffe H, Singh B, Shah S, Nagaraju K, Varsani H, Gao B, Wedderburn LR: Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis. Implications for juvenile myositis. Am J Pathol. 2009, 175: 1030-1040. 10.2353/ajpath.2009.090196.
PubMed Central
CAS
PubMed
Google Scholar
Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L: Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther. 2010, 12: R52-10.1186/ar2963.
PubMed Central
PubMed
Google Scholar
Vattemi G, Engel WK, McFerrin J, Askanas V: Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol. 2004, 164: 1-7. 10.1016/S0002-9440(10)63089-1.
PubMed Central
CAS
PubMed
Google Scholar
Temiz P, Weihl CC, Pestronk A: Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci. 2009, 278: 25-29. 10.1016/j.jns.2008.11.010.
PubMed
Google Scholar
Miro O, Casademont J, Grau JM, Jarreta D, Urbano-Marquez A, Cardellach F: Histological and biochemical assessment of mitochondrial function in dermatomyositis. Br J Rheumatol. 1998, 37: 1047-1053. 10.1093/rheumatology/37.10.1047.
CAS
PubMed
Google Scholar
Alhatou MI, Sladky JT, Bagasra O, Glass JD: Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology. J Mol Histol. 2004, 35: 615-619. 10.1007/s10735-004-2194-6.
PubMed
Google Scholar
Hardin BJ, Campbell KS, Smith JD, Arbogast S, Smith J, Moylan JS, Reid MB: TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J Appl Physiol. 2008, 104: 694-699. 10.1152/japplphysiol.00898.2007.
CAS
PubMed
Google Scholar
Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S: Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol. 2002, 169: 6668-6672.
CAS
PubMed
Google Scholar
Roux S, Seelig HP, Meyer O: Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis. J Rheumatol. 1998, 25: 395-396.
CAS
PubMed
Google Scholar
Schroder JM, Molnar M: Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis. Mol Cell Biochem. 1997, 174: 277-281. 10.1023/A:1006829129079.
CAS
PubMed
Google Scholar
Fishbein WN: Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med. 1985, 33: 158-169. 10.1016/0006-2944(85)90024-9.
CAS
PubMed
Google Scholar
Sabina RL, Swain JL, Olanow CW, Bradley WG, Fishbein WN, DiMauro S, Holmes EW: Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest. 1984, 73: 720-730. 10.1172/JCI111265.
PubMed Central
CAS
PubMed
Google Scholar
Pistilli EE, Guo G, Stauber WT: IL-15Ralpha deficiency leads to mitochondrial and myofiber differences in fast mouse muscles. Cytokine. 2012, 61: 41-45.
PubMed
Google Scholar
Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, Danning C, Wada R, Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P: Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A. 2000, 97: 9209-9214. 10.1073/pnas.97.16.9209.
PubMed Central
CAS
PubMed
Google Scholar
Askanas V, Engel WK: Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-beta42 oligomers and phosphorylated tau. Presse Med. 2011, 40: e219-e235. 10.1016/j.lpm.2010.11.024.
PubMed
Google Scholar
Paepe BD, Creus KK, Weis J, Bleecker JL: Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction. Neuromuscul Disord. 2012, 22: 26-33. 10.1016/j.nmd.2011.07.007.
PubMed
Google Scholar
Rayavarapu S, Coley W, Nagaraju K: Endoplasmic reticulum stress in skeletal muscle homeostasis and disease. Curr Rheumatol Rep. 2012, 14: 238-243. 10.1007/s11926-012-0247-5.
PubMed Central
CAS
PubMed
Google Scholar
Nogalska A, D'Agostino C, Engel WK, Askanas V: Activation of the gamma-secretase complex and presence of gamma-secretase-activating protein may contribute to Abeta42 production in sporadic inclusion-body myositis muscle fibers. Neurobiol Dis. 2012, 48: 141-149. 10.1016/j.nbd.2012.06.008.
CAS
PubMed
Google Scholar
Keller CW, Fokken C, Turville SG, Lünemann A, Schmidt J, Münz C, Lünemann JD: TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells. J Biol Chem. 2011, 286: 3970-3980. 10.1074/jbc.M110.159392.
PubMed Central
CAS
PubMed
Google Scholar
Sugihara T, Okiyama N, Watanabe N, Miyasaka N, Kohsaka H: Interleukin-1 and tumor necrosis factor alpha blockade treatment of experimental polymyositis in mice. Arthritis Rheum. 2012, 64: 2655-2662. 10.1002/art.34465.
CAS
PubMed
Google Scholar
Doyle A, Zhang G, Abdel Fattah EA, Eissa NT, Li YP: Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J. 2011, 25: 99-110. 10.1096/fj.10-164152.
PubMed Central
CAS
PubMed
Google Scholar